Effect of oral N-acetylcysteine on COPD patients with microsatellite polymorphism in the heme oxygenase-1 gene promoter

References

• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201318734736522878278
   PubMed Web of Science ®Google Scholar
• KirkhamPABarnesPJOxidative stress in COPDChest2013144126627323880677
   PubMed Web of Science ®Google Scholar
• SethiSMahlerDAMarcusPOwenCAYawnBRennardSInflammation in COPD: implications for managementAm J Med20121251162117023164484
   PubMed Web of Science ®Google Scholar
• European Innovation Partnership on A, Healthy Ageing APB, Mechanisms of the Development of Allergy WPIntegrated care pathways for airway diseases (AIRWAYS-ICPs)Eur Respir J20144430432324925919
   PubMed Web of Science ®Google Scholar
• GronkeLBeehKMCameronREffect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary diseasePulm Pharmacol Ther20082140941718063399
   PubMed Web of Science ®Google Scholar
• VlahosRBozinovskiSChanSPNeutralizing granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammationAm J Respir Crit Care Med2010182344020203243
   PubMed Web of Science ®Google Scholar
• WoodruffPGAlbertRKBaileyWCRandomized trial of zileuton for treatment of COPD exacerbations requiring hospitalizationCOPD20118212921299475
   PubMedGoogle Scholar
• DunnLLMidwinterRGNiJHamidHAParishCRStockerRNew insights into intracellular locations and functions of heme oxygenase-1Antioxid Redox Signal2014201723174224180287
   PubMed Web of Science ®Google Scholar
• GerritsCMJMHeringsRMCLeufkensHGMLammersJWN-Acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary diseaseEur Respir J20032179579812765423
   PubMed Web of Science ®Google Scholar
• DecramerMRutten-van MölkenMDekhuijzenPNREffects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trialLancet20053651552156015866309
   PubMed Web of Science ®Google Scholar
• SutherlandERCrapoJDBowlerRPN-Acetylcysteine and exacerbations of chronic obstructive pulmonary diseaseCOPD2006319520217361500
   PubMedGoogle Scholar
• ShenYCaiWLeiSZhangZEffect of high/low dose N-acetylcysteine on chronic obstructive pulmonary disease: a systematic review and meta-analysisCOPD201411335135824378052
   PubMedGoogle Scholar
• StavDRazMEffect of N-acetylcysteine on air trapping in COPDChest2009136238138619447919
   PubMed Web of Science ®Google Scholar
• De BackerJVosWVan HolsbekeCEffect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patientsInt J Chron Obstruct Pulmon Dis2013856957924293993
   PubMed Web of Science ®Google Scholar
• TseHNRaiteriLWongKYHigh-dose N-acetylcysteine in stable COPDChest2013144110611823348146
   PubMed Web of Science ®Google Scholar
• SinojiaRShaikhMKodguleRPriming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200 mg/day NAC in moderate to severe COPD patients: a pilot studyRespir Physiol Neurobiol2014191525924211316
   PubMed Web of Science ®Google Scholar
• ZhengJPWenFQBaiCXTwice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trialLancet Respir Med20142318719424621680
   PubMed Web of Science ®Google Scholar
• RushworthGFMegsonILExisting and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefitsPharmacol Ther2014141215015924080471
   PubMed Web of Science ®Google Scholar
• TseHNTsengCZUpdate on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2014982583625125976
   PubMed Web of Science ®Google Scholar
• MotterliniRForestiRHeme oxygenase-1 as a target for drug discoveryAntioxid Redox Signal201420111810182624180608
   PubMed Web of Science ®Google Scholar
• DenneryPASignaling function of heme oxygenase proteinsAntioxid Redox Signal201420111743175324180238
   PubMed Web of Science ®Google Scholar
• YamadaNYamayaMOkinagaSMicrosatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysemaAm J Hum Genet200066118719510631150
   PubMed Web of Science ®Google Scholar
• NakayamaKKikuchiAYasudaHHeme oxygenase-1 gene promoter polymorphism and decline in lung function in Japanese menThorax2006611092117008486
   PubMed Web of Science ®Google Scholar
• GuénégouALeynaertBBénessianoJAssociation of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), FranceJ Med Genet200643e4316882737
   PubMed Web of Science ®Google Scholar
• FuWPSunCDaiLMYangLFZhangYPRelationship between COPD and polymorphisms of HOX-1 and mEPH in a Chinese populationOncol Rep200717248348817203192
   PubMed Web of Science ®Google Scholar
• TanakaGAminuddinFAkhabirLEffect of heme oxygenase-1 polymorphisms on lung function and gene expressionBMC Med Genet20111211721902835
   PubMed Web of Science ®Google Scholar
• HeJQRuanJConnettJEAnthonisenNRParéPDSandfordAJAntioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokersAm J Respir Crit Care Med2002166332332812153964
   PubMed Web of Science ®Google Scholar
• PelaRCalcagniAMSubiacoSIsidoriPTubaldiASanguinettiCMN-Acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPDRespiration199966649550010575333
   PubMed Web of Science ®Google Scholar
• ZhengJPKangJHuangSGEffect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE study): a randomised placebo-controlled studyLancet200837196292013201818555912
   PubMed Web of Science ®Google Scholar
• AlmolkiAGuénégouAGoldaSHeme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humansAm J Pathol2008173498199218787101
   PubMed Web of Science ®Google Scholar